Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 767

1.

Cooperation of genes in HPV16 E6/E7-dependent cervico-vaginal carcinogenesis trackable by endoscopy and independent of exogenous estrogens or carcinogens.

Böttinger P, Schreiber K, Hyjek E, Krausz T, Spiotto MT, Steiner M, Idel C, Booras H, Beck-Engeser G, Riederer J, Willimsky G, Wolf SP, Karrison T, Jensen E, Weichselbaum RR, Nakamura Y, Yew PY, Lambert PF, Kurita T, Kiyotani K, Leisegang M, Schreiber H.

Carcinogenesis. 2020 Mar 28. pii: bgaa027. doi: 10.1093/carcin/bgaa027. [Epub ahead of print]

PMID:
32221533
2.

Prostate specific membrane antigen (PSMA) in urothelial cell carcinoma (UCC) is associated with tumor grading and staging.

Schreiber H, Hänze J, Nimphius W, Verburg FA, Luster M, Hofmann R, Hegele A.

J Cancer Res Clin Oncol. 2020 Feb;146(2):305-313. doi: 10.1007/s00432-019-03113-9. Epub 2020 Jan 2.

PMID:
31897687
3.

Impact of TCR Diversity on the Development of Transplanted or Chemically Induced Tumors.

Schreiber K, Karrison TG, Wolf SP, Kiyotani K, Steiner M, Littmann ER, Pamer EG, Kammertoens T, Schreiber H, Leisegang M.

Cancer Immunol Res. 2020 Feb;8(2):192-202. doi: 10.1158/2326-6066.CIR-19-0567. Epub 2019 Dec 12.

PMID:
31831634
4.

Multiple cancer-specific antigens are targeted by a chimeric antigen receptor on a single cancer cell.

He Y, Schreiber K, Wolf SP, Wen F, Steentoft C, Zerweck J, Steiner M, Sharma P, Shepard HM, Posey A, June CH, Mandel U, Clausen H, Leisegang M, Meredith SC, Kranz DM, Schreiber H.

JCI Insight. 2019 Dec 5;4(23). pii: 135306. doi: 10.1172/jci.insight.135306. No abstract available.

5.

Multiple cancer-specific antigens are targeted by a chimeric antigen receptor on a single cancer cell.

He Y, Schreiber K, Wolf SP, Wen F, Steentoft C, Zerweck J, Steiner M, Sharma P, Shepard HM, Posey A, June CH, Mandel U, Clausen H, Leisegang M, Meredith SC, Kranz DM, Schreiber H.

JCI Insight. 2019 Nov 1;4(21). pii: 130416. doi: 10.1172/jci.insight.130416. Erratum in: JCI Insight. 2019 Dec 5;4(23):.

6.

Neoadjuvant PD-1 Immune Checkpoint Blockade Reverses Functional Immunodominance among Tumor Antigen-Specific T Cells.

Friedman J, Moore EC, Zolkind P, Robbins Y, Clavijo PE, Sun L, Greene S, Morisada MV, Mydlarz WK, Schmitt N, Hodge JW, Schreiber H, Van Waes C, Uppaluri R, Allen C.

Clin Cancer Res. 2020 Feb 1;26(3):679-689. doi: 10.1158/1078-0432.CCR-19-2209. Epub 2019 Oct 23.

PMID:
31645352
7.

TCR-pMHC bond conformation controls TCR ligand discrimination.

Sasmal DK, Feng W, Roy S, Leung P, He Y, Cai C, Cao G, Lian H, Qin J, Hui E, Schreiber H, Adams EJ, Huang J.

Cell Mol Immunol. 2020 Mar;17(3):203-217. doi: 10.1038/s41423-019-0273-6. Epub 2019 Sep 17.

8.

Can the Need for Invasive Intervention in Tubo-ovarian Abscess Be Predicted? The Implication of C-reactive Protein Measurements.

Ribak R, Schonman R, Sharvit M, Schreiber H, Raviv O, Klein Z.

J Minim Invasive Gynecol. 2020 Feb;27(2):541-547. doi: 10.1016/j.jmig.2019.04.027. Epub 2019 Aug 31.

PMID:
31479751
9.

Macrolide antibiotics roxithromycin vs. azithromycin for preterm premature rupture of membranes: a retrospective comparison.

Schreiber H, Shitrit P, Man-El G, Engel O, Berkovitz A, Biron-Shental T.

Arch Gynecol Obstet. 2019 Sep;300(3):569-573. doi: 10.1007/s00404-019-05221-w. Epub 2019 Jun 22.

PMID:
31227871
10.

Barcodes of Towers and a Streaming Algorithm for Persistent Homology.

Kerber M, Schreiber H.

Discrete Comput Geom. 2019;61(4):852-879. doi: 10.1007/s00454-018-0030-0. Epub 2018 Oct 1.

11.

Adverse pregnancy outcomes and multiple nuchal cord loops.

Schreiber H, Daykan Y, Arbib N, Markovitch O, Berkovitz A, Biron-Shental T.

Arch Gynecol Obstet. 2019 Aug;300(2):279-283. doi: 10.1007/s00404-019-05178-w. Epub 2019 May 7.

PMID:
31065803
12.

A strategy for generating cancer-specific monoclonal antibodies to aberrant O-glycoproteins: identification of a novel dysadherin-Tn antibody.

Steentoft C, Fuhrmann M, Battisti F, Van Coillie J, Madsen TD, Campos D, Halim A, Vakhrushev SY, Joshi HJ, Schreiber H, Mandel U, Narimatsu Y.

Glycobiology. 2019 Apr 1;29(4):307-319. doi: 10.1093/glycob/cwz004.

13.

Fibroblasts: Dangerous travel companions.

Schreiber H.

J Exp Med. 2019 Mar 4;216(3):479-481. doi: 10.1084/jem.20181850. Epub 2019 Feb 1.

14.

Twin pregnancies and perinatal outcomes: a comparison between fresh and frozen embryo transfer: a two-centre study.

Shavit M, Miller N, Schreiber H, Asali A, Ravid D, Harlev A, Levitas E, Har-Vardi I, Berkovitz A.

Reprod Biomed Online. 2019 Feb;38(2):241-248. doi: 10.1016/j.rbmo.2018.11.004. Epub 2018 Dec 7.

PMID:
30579823
15.

SACS variants are a relevant cause of autosomal recessive hereditary motor and sensory neuropathy.

Vill K, Müller-Felber W, Gläser D, Kuhn M, Teusch V, Schreiber H, Weis J, Klepper J, Schirmacher A, Blaschek A, Wiessner M, Strom TM, Dräger B, Hofmeister-Kiltz K, Tacke M, Gerstl L, Young P, Horvath R, Senderek J.

Hum Genet. 2018 Dec;137(11-12):911-919. doi: 10.1007/s00439-018-1952-6. Epub 2018 Nov 21.

PMID:
30460542
16.

MPV17 mutations in juvenile- and adult-onset axonal sensorimotor polyneuropathy.

Baumann M, Schreiber H, Schlotter-Weigel B, Löscher WN, Stucka R, Karall D, Strom TM, Bauer P, Krabichler B, Fauth C, Glaeser D, Senderek J.

Clin Genet. 2019 Jan;95(1):182-186. doi: 10.1111/cge.13462. Epub 2018 Oct 25.

PMID:
30298599
17.

Prostate cancer tissues with positive TMPRSS2-ERG-gene-fusion status may display enhanced nerve density.

Hänze J, Rexin P, Jakubowski P, Schreiber H, Heers H, Lingelbach S, Kinscherf R, Weihe E, Hofmann R, Hegele A.

Urol Oncol. 2020 Jan;38(1):3.e7-3.e15. doi: 10.1016/j.urolonc.2018.07.019. Epub 2018 Sep 18.

PMID:
30241953
18.

The Brief International Cognitive Assessment in Multiple Sclerosis (BICAMS): results from the German validation study.

Filser M, Schreiber H, Pöttgen J, Ullrich S, Lang M, Penner IK.

J Neurol. 2018 Nov;265(11):2587-2593. doi: 10.1007/s00415-018-9034-1. Epub 2018 Aug 31.

PMID:
30171410
19.

Epidemiology and biology of relapse after stem cell transplantation.

Horowitz M, Schreiber H, Elder A, Heidenreich O, Vormoor J, Toffalori C, Vago L, Kröger N.

Bone Marrow Transplant. 2018 Nov;53(11):1379-1389. doi: 10.1038/s41409-018-0171-z. Epub 2018 Apr 18. Review. No abstract available.

20.

Precision antimicrobial therapeutics: the path of least resistance?

Spaulding CN, Klein RD, Schreiber HL 4th, Janetka JW, Hultgren SJ.

NPJ Biofilms Microbiomes. 2018 Feb 27;4:4. doi: 10.1038/s41522-018-0048-3. eCollection 2018. Review.

21.

Functional role of the type 1 pilus rod structure in mediating host-pathogen interactions.

Spaulding CN, Schreiber HL 4th, Zheng W, Dodson KW, Hazen JE, Conover MS, Wang F, Svenmarker P, Luna-Rico A, Francetic O, Andersson M, Hultgren S, Egelman EH.

Elife. 2018 Jan 18;7. pii: e31662. doi: 10.7554/eLife.31662.

22.

Narrowing the spectrum: the new frontier of precision antimicrobials.

Paharik AE, Schreiber HL 4th, Spaulding CN, Dodson KW, Hultgren SJ.

Genome Med. 2017 Dec 14;9(1):110. doi: 10.1186/s13073-017-0504-3. Review.

23.

Catheterization alters bladder ecology to potentiate Staphylococcus aureus infection of the urinary tract.

Walker JN, Flores-Mireles AL, Pinkner CL, Schreiber HL 4th, Joens MS, Park AM, Potretzke AM, Bauman TM, Pinkner JS, Fitzpatrick JAJ, Desai A, Caparon MG, Hultgren SJ.

Proc Natl Acad Sci U S A. 2017 Oct 10;114(41):E8721-E8730. doi: 10.1073/pnas.1707572114. Epub 2017 Sep 25.

24.

Selective depletion of uropathogenic E. coli from the gut by a FimH antagonist.

Spaulding CN, Klein RD, Ruer S, Kau AL, Schreiber HL, Cusumano ZT, Dodson KW, Pinkner JS, Fremont DH, Janetka JW, Remaut H, Gordon JI, Hultgren SJ.

Nature. 2017 Jun 22;546(7659):528-532. doi: 10.1038/nature22972. Epub 2017 Jun 14.

25.

Combined Analysis of Extant Rhynchonellida (Brachiopoda) using Morphological and Molecular Data.

Bapst DW, Schreiber HA, Carlson SJ.

Syst Biol. 2018 Jan 1;67(1):32-48. doi: 10.1093/sysbio/syx049.

26.

Tumour ischaemia by interferon-γ resembles physiological blood vessel regression.

Kammertoens T, Friese C, Arina A, Idel C, Briesemeister D, Rothe M, Ivanov A, Szymborska A, Patone G, Kunz S, Sommermeyer D, Engels B, Leisegang M, Textor A, Fehling HJ, Fruttiger M, Lohoff M, Herrmann A, Yu H, Weichselbaum R, Uckert W, Hübner N, Gerhardt H, Beule D, Schreiber H, Blankenstein T.

Nature. 2017 May 4;545(7652):98-102. doi: 10.1038/nature22311. Epub 2017 Apr 26.

27.

Bacterial virulence phenotypes of Escherichia coli and host susceptibility determine risk for urinary tract infections.

Schreiber HL 4th, Conover MS, Chou WC, Hibbing ME, Manson AL, Dodson KW, Hannan TJ, Roberts PL, Stapleton AE, Hooton TM, Livny J, Earl AM, Hultgren SJ.

Sci Transl Med. 2017 Mar 22;9(382). pii: eaaf1283. doi: 10.1126/scitranslmed.aaf1283.

28.

One size doesn't fit all: unraveling the diversity of factors and interactions that drive E. coli urovirulence.

Schreiber HL 4th, Spaulding CN, Dodson KW, Livny J, Hultgren SJ.

Ann Transl Med. 2017 Jan;5(2):28. doi: 10.21037/atm.2016.12.73. No abstract available.

29.

Transfer of Allogeneic CD4+ T Cells Rescues CD8+ T Cells in Anti-PD-L1-Resistant Tumors Leading to Tumor Eradication.

Arina A, Karrison T, Galka E, Schreiber K, Weichselbaum RR, Schreiber H.

Cancer Immunol Res. 2017 Feb;5(2):127-136. doi: 10.1158/2326-6066.CIR-16-0293. Epub 2017 Jan 11.

30.

Baseline predictors of persistence to first disease-modifying treatment in multiple sclerosis.

Zettl UK, Schreiber H, Bauer-Steinhusen U, Glaser T, Hechenbichler K, Hecker M; BETAPATH Study Group.

Acta Neurol Scand. 2017 Aug;136(2):116-121. doi: 10.1111/ane.12705. Epub 2016 Oct 30.

PMID:
27796033
31.

Antibody-Based Therapy for Enterococcal Catheter-Associated Urinary Tract Infections.

Flores-Mireles AL, Walker JN, Potretzke A, Schreiber HL 4th, Pinkner JS, Bauman TM, Park AM, Desai A, Hultgren SJ, Caparon MG.

mBio. 2016 Oct 25;7(5). pii: e01653-16. doi: 10.1128/mBio.01653-16.

32.

Tumor relapse prevented by combining adoptive T cell therapy with Salmonella typhimurium.

Binder DC, Arina A, Wen F, Tu T, Zhao M, Hoffman RM, Wainwright DA, Schreiber H.

Oncoimmunology. 2016 Feb 18;5(6):e1130207. doi: 10.1080/2162402X.2015.1130207. eCollection 2016 Jun.

33.

Engineered CAR T Cells Targeting the Cancer-Associated Tn-Glycoform of the Membrane Mucin MUC1 Control Adenocarcinoma.

Posey AD Jr, Schwab RD, Boesteanu AC, Steentoft C, Mandel U, Engels B, Stone JD, Madsen TD, Schreiber K, Haines KM, Cogdill AP, Chen TJ, Song D, Scholler J, Kranz DM, Feldman MD, Young R, Keith B, Schreiber H, Clausen H, Johnson LA, June CH.

Immunity. 2016 Jun 21;44(6):1444-54. doi: 10.1016/j.immuni.2016.05.014.

34.

Tumor-associated fibroblasts predominantly come from local and not circulating precursors.

Arina A, Idel C, Hyjek EM, Alegre ML, Wang Y, Bindokas VP, Weichselbaum RR, Schreiber H.

Proc Natl Acad Sci U S A. 2016 Jul 5;113(27):7551-6. doi: 10.1073/pnas.1600363113. Epub 2016 Jun 17.

35.

Inducible targeting of cDCs and their subsets in vivo.

Loschko J, Rieke GJ, Schreiber HA, Meredith MM, Yao KH, Guermonprez P, Nussenzweig MC.

J Immunol Methods. 2016 Jul;434:32-8. doi: 10.1016/j.jim.2016.04.004. Epub 2016 Apr 9.

36.

Absence of MHC class II on cDCs results in microbial-dependent intestinal inflammation.

Loschko J, Schreiber HA, Rieke GJ, Esterházy D, Meredith MM, Pedicord VA, Yao KH, Caballero S, Pamer EG, Mucida D, Nussenzweig MC.

J Exp Med. 2016 Apr 4;213(4):517-34. doi: 10.1084/jem.20160062. Epub 2016 Mar 21.

37.

Fibrinogen Release and Deposition on Urinary Catheters Placed during Urological Procedures.

Flores-Mireles AL, Walker JN, Bauman TM, Potretzke AM, Schreiber HL 4th, Park AM, Pinkner JS, Caparon MG, Hultgren SJ, Desai A.

J Urol. 2016 Aug;196(2):416-421. doi: 10.1016/j.juro.2016.01.100. Epub 2016 Jan 28.

38.

Eradication of Large Solid Tumors by Gene Therapy with a T-Cell Receptor Targeting a Single Cancer-Specific Point Mutation.

Leisegang M, Engels B, Schreiber K, Yew PY, Kiyotani K, Idel C, Arina A, Duraiswamy J, Weichselbaum RR, Uckert W, Nakamura Y, Schreiber H.

Clin Cancer Res. 2016 Jun 1;22(11):2734-43. doi: 10.1158/1078-0432.CCR-15-2361. Epub 2015 Dec 14.

39.

Mycobacterium-Infected Dendritic Cells Disseminate Granulomatous Inflammation.

Harding JS, Rayasam A, Schreiber HA, Fabry Z, Sandor M.

Sci Rep. 2015 Oct 30;5:15248. doi: 10.1038/srep15248.

40.

Editorial overview: tumour immunology.

Schreiber H, Greenberg P.

Curr Opin Immunol. 2015 Apr;33:ix-xi. doi: 10.1016/j.coi.2015.03.006. Epub 2015 Mar 27. No abstract available.

PMID:
25823946
41.

Targeting cancer-specific mutations by T cell receptor gene therapy.

Blankenstein T, Leisegang M, Uckert W, Schreiber H.

Curr Opin Immunol. 2015 Apr;33:112-9. doi: 10.1016/j.coi.2015.02.005. Epub 2015 Feb 27. Review.

42.

Is personality profile a relevant determinant of fatigue in multiple sclerosis?

Schreiber H, Lang M, Kiltz K, Lang C.

Front Neurol. 2015 Feb 4;6:2. doi: 10.3389/fneur.2015.00002. eCollection 2015. Review.

43.

Classification of current anticancer immunotherapies.

Galluzzi L, Vacchelli E, Bravo-San Pedro JM, Buqué A, Senovilla L, Baracco EE, Bloy N, Castoldi F, Abastado JP, Agostinis P, Apte RN, Aranda F, Ayyoub M, Beckhove P, Blay JY, Bracci L, Caignard A, Castelli C, Cavallo F, Celis E, Cerundolo V, Clayton A, Colombo MP, Coussens L, Dhodapkar MV, Eggermont AM, Fearon DT, Fridman WH, Fučíková J, Gabrilovich DI, Galon J, Garg A, Ghiringhelli F, Giaccone G, Gilboa E, Gnjatic S, Hoos A, Hosmalin A, Jäger D, Kalinski P, Kärre K, Kepp O, Kiessling R, Kirkwood JM, Klein E, Knuth A, Lewis CE, Liblau R, Lotze MT, Lugli E, Mach JP, Mattei F, Mavilio D, Melero I, Melief CJ, Mittendorf EA, Moretta L, Odunsi A, Okada H, Palucka AK, Peter ME, Pienta KJ, Porgador A, Prendergast GC, Rabinovich GA, Restifo NP, Rizvi N, Sautès-Fridman C, Schreiber H, Seliger B, Shiku H, Silva-Santos B, Smyth MJ, Speiser DE, Spisek R, Srivastava PK, Talmadge JE, Tartour E, Van Der Burg SH, Van Den Eynde BJ, Vile R, Wagner H, Weber JS, Whiteside TL, Wolchok JD, Zitvogel L, Zou W, Kroemer G.

Oncotarget. 2014 Dec 30;5(24):12472-508. Review.

44.

Drug-resistant MS spasticity treatment with Sativex(®) add-on and driving ability.

Freidel M, Tiel-Wilck K, Schreiber H, Prechtl A, Essner U, Lang M.

Acta Neurol Scand. 2015 Jan;131(1):9-16. doi: 10.1111/ane.12287. Epub 2014 Sep 11.

PMID:
25208898
45.

High-affinity peptide-based anticancer vaccination to overcome resistance to immunostimulatory antibodies.

Binder DC, Schreiber H.

Oncoimmunology. 2013 Dec 1;2(12):e26704. Epub 2013 Oct 22.

46.

Longitudinal confocal microscopy imaging of solid tumor destruction following adoptive T cell transfer.

Schietinger A, Arina A, Liu RB, Wells S, Huang J, Engels B, Bindokas V, Bartkowiak T, Lee D, Herrmann A, Piston DW, Pittet MJ, Lin PC, Zal T, Schreiber H.

Oncoimmunology. 2013 Nov 1;2(11):e26677. Epub 2013 Nov 4.

47.

Antigen-specific bacterial vaccine combined with anti-PD-L1 rescues dysfunctional endogenous T cells to reject long-established cancer.

Binder DC, Engels B, Arina A, Yu P, Slauch JM, Fu YX, Karrison T, Burnette B, Idel C, Zhao M, Hoffman RM, Munn DH, Rowley DA, Schreiber H.

Cancer Immunol Res. 2013 Aug;1(2):123-33. doi: 10.1158/2326-6066.CIR-13-0058.

48.

Dual blockade of PD-1 and CTLA-4 combined with tumor vaccine effectively restores T-cell rejection function in tumors--letter.

Binder DC, Schreiber H.

Cancer Res. 2014 Jan 15;74(2):632; discussion 635. doi: 10.1158/0008-5472.CAN-13-2216. Epub 2014 Jan 9. No abstract available.

49.

Adoptively transferred immune T cells eradicate established tumors despite cancer-induced immune suppression.

Arina A, Schreiber K, Binder DC, Karrison TG, Liu RB, Schreiber H.

J Immunol. 2014 Feb 1;192(3):1286-93. doi: 10.4049/jimmunol.1202498. Epub 2013 Dec 23.

50.

Essential yet limited role for CCR2⁺ inflammatory monocytes during Mycobacterium tuberculosis-specific T cell priming.

Samstein M, Schreiber HA, Leiner IM, Susac B, Glickman MS, Pamer EG.

Elife. 2013 Nov 12;2:e01086. doi: 10.7554/eLife.01086.

Supplemental Content

Loading ...
Support Center